Toll-Like Receptor 7 Staining in Malignant Epithelial Tumors

被引:1
作者
Franz, Regina [1 ]
Ritter, Nathalie [1 ]
Hein, Ruediger [1 ]
Biedermann, Tilo [1 ]
Al-Sisi, Mohammed [1 ]
Eyerich, Kilian [1 ]
Garzorz-Stark, Natalie [1 ]
Andres, Christian [1 ,2 ]
机构
[1] Tech Univ Munich, Dept Dermatol & Allergy, Munich, Germany
[2] Labor Dermatohistol, Sonnenstr 7, D-80331 Munich, Germany
基金
欧盟地平线“2020”;
关键词
Toll-like receptor 7; squamous cell carcinoma; basal cell carcinoma; basosquamous carcinoma; SQUAMOUS-CELL CARCINOMA; IMIQUIMOD; AGONIST; CANCER;
D O I
10.1097/DAD.0000000000000784
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: As important players of the innate immune system, Toll-like receptors (TLRs) and their role for tumorigenesis have been in the focus of research. In particular TLR7 is an interesting candidate, as TLR7 agonists are broadly used for the treatment of cutaneous tumors. However, data addressing the baseline expression of TLR7 in both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) on the protein level are lacking, while on the genomic level significantly elevated expression of TLR7 in SCC but not in BCC has been demonstrated. Aim: Our aim was to characterize the immunohistochemical staining pattern of TLR7 in SCC and BCC. Besides, we aimed to clarify if, in case of different TLR7 expression between SCC and BCC, TLR7 expression would help to define basosquamous carcinoma (BSC), a tumor entity sharing characteristics of both SCC and BCC. Methods: We examined histopathological samples from 23 BCC, 4 BSC, and 24 SCC and characterized the expression of TLR7 by immunohistochemistry and immunofluorescence. Results: We found that TLR7 was not expressed by the tumor tissue of SCC, BCC, and BSC, but by inflammatory cells located within the tumoral and/or peritumoral tissue. Whereas the overall expression of TLR7 did not differ between BCC and SCC (30.4% vs. 45.8%, respectively), we found that within the group of SCC, the well-differentiated SCC showed strong tumoral and/or peritumoral immunocellular TLR7 reactivity in contrast to the poorly differentiated SCC (73.33% vs. 11.1%, respectively). Besides, immunofluorescence double staining revealed the expression of TLR7 in immune cells closely interacting with T cells and natural killer cells. Conclusions: In contrast to genomic data, we did not find a general difference between baseline TLR7 expression of SCC and BCC on the protein level. Nevertheless, the expression of TLR7 by the inflammatory infiltrate associated with SCC may correlate with the degree of differentiation of SCC possibly indicating better outcome.
引用
收藏
页码:742 / 746
页数:5
相关论文
共 50 条
  • [21] Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance
    Michaelis, Katherine A.
    Norgard, Mason A.
    Levasseur, Peter R.
    Olson, Brennan
    Burfeind, Kevin G.
    Buenafe, Abigail C.
    Zhu, Xinxia
    Jeng, Sophia
    McWeeney, Shannon K.
    Marks, Daniel L.
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 82 : 338 - 353
  • [22] Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists
    Debnath, Sashi
    Hao, Guiyang
    Guan, Bing
    Thapa, Pawan
    Hao, Justin
    Hammers, Hans
    Sun, Xiankai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [23] Targeted Activation of Toll-Like Receptors: Conjugation of a Toll-Like Receptor 7 Agonist to a Monoclonal Antibody Maintains Antigen Binding and Specificity
    Gadd, Adam J. R.
    Greco, Francesca
    Cobb, Alexander J. A.
    Edwards, Alexander D.
    BIOCONJUGATE CHEMISTRY, 2015, 26 (08) : 1743 - 1752
  • [24] Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine
    Wolska, Anna
    Cebula-Obrzut, Barbara
    Smolewski, Piotr
    Robak, Tadeusz
    LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1268 - 1278
  • [25] Toll-like receptors in health and disease
    Wang, Kunyu
    Huang, Hanyao
    Zhan, Qi
    Ding, Haoran
    Li, Yi
    MEDCOMM, 2024, 5 (05):
  • [26] Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs
    Kaufman, Elad H.
    Fryer, Allison D.
    Jacoby, David B.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : 462 - 469
  • [27] Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse
    Lee, A. S.
    Ghoreishi, M.
    Cheng, W. K.
    Chang, T. -Y. E.
    Zhang, Y. Q.
    Dutz, J. P.
    DIABETOLOGIA, 2011, 54 (06) : 1407 - 1416
  • [28] Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures
    Meyer, T
    Nindl, I
    Schmook, T
    Ulrich, C
    Sterry, W
    Stockfleth, E
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 9 - 13
  • [29] High expression of Toll-like receptor 7 is a survival factor in pediatric medulloblastoma
    Alvarez-Arellano, Lourdes
    Eguia-Aguilar, Pilar
    Pina-Sanchez, Patricia
    Gonzalez-Garcia, Nadia
    Palma-Guzman, Alam
    Perezpena-Diazconti, Mario
    Maldonado-Bernal, Carmen
    CHILDS NERVOUS SYSTEM, 2021, 37 (12) : 3743 - 3752
  • [30] Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
    Hao Sun
    Yingmei Li
    Peng Zhang
    Haizhou Xing
    Song Zhao
    Yongping Song
    Dingming Wan
    Jifeng Yu
    Biomarker Research, 10